[HTML][HTML] Evaluating eligibility criteria of oncology trials using real-world data and AI
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging,–. Here we systematically evaluate the effect of …
eligibility criteria remains challenging,–. Here we systematically evaluate the effect of …
Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - Nature, 2021 - ideas.repec.org
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging1–3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging1–3. Here we systematically evaluate the effect of …
Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - Nature, 2021 - econpapers.repec.org
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging1–3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging1–3. Here we systematically evaluate the effect of …
Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - …, 2021 - ui.adsabs.harvard.edu
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging 1-3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging 1-3. Here we systematically evaluate the effect of …
Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - paper.sciencenet.cn
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging1, 2, 3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging1, 2, 3. Here we systematically evaluate the effect of …
[引用][C] Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - Nature, 2021 - cir.nii.ac.jp
Evaluating eligibility criteria of oncology trials using real-world data and AI | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda… - …, 2021 - pubmed.ncbi.nlm.nih.gov
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging 1-3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging 1-3. Here we systematically evaluate the effect of …
Evaluating eligibility criteria of oncology trials using real-world data and AI.
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - Nature, 2021 - europepmc.org
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging 1–3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging 1–3. Here we systematically evaluate the effect of …
[HTML][HTML] Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - Nature, 2021 - ncbi.nlm.nih.gov
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging 1–3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging 1–3. Here we systematically evaluate the effect of …
Evaluating eligibility criteria of oncology trials using real-world data and AI
R Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu… - …, 2021 - ui.adsabs.harvard.edu
There is a growing focus on making clinical trials more inclusive but the design of trial
eligibility criteria remains challenging 1-3. Here we systematically evaluate the effect of …
eligibility criteria remains challenging 1-3. Here we systematically evaluate the effect of …